Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate vs Parental Training in Preschool ADHD
NCT02807870Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Universidade de São Paulo. Primary endpoints: Change in attention deficit and hyperactivity symptoms at 3 years, Change in symptom severity at 3 years and 1 more. Started Jun 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02807870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807870.